Apyx Medical Corporation Issues Preliminary Revenue Results for Q4 and Full Year 2024

On January 13, 2025, Apyx Medical Corporation (NYSEAMERICAN: BVX) released a press statement revealing its preliminary revenue outcomes for the fourth quarter as well as the entirety of the fiscal year ending December 31, 2024.

According to the report, the details of which were disclosed in a Current Report on Form 8-K, the full press release regarding the revenue results has been provided as Exhibit 99.1 attached to the filing. This information has been shared in compliance with Item 2.02 guidelines. It is essential to note that the content of this report, including the attached press release (Exhibit 99.1), is being furnished for informational purposes and should not be considered as being officially “filed” for the stipulations outlined in Section 18 of the Securities Exchange Act of 1934, as amended, or subjected to the responsibilities associated with that section. The inclusion of this information does not imply an admission regarding its materiality.

In adherence to the requirements outlined under Item 9.01, the financial statements and accompanying exhibits are duly noted, with Exhibit 99.1 comprising the press release dated January 13, 2025, and Exhibit 104 consisting of the Cover Page Interactive Data File embedded within the Inline XBRL document.

As per the closing statements of the filing, a signed confirmation by Matthew Hill, who serves as Apyx Medical Corporation’s Chief Financial Officer, Secretary, and Treasurer, confirms the authenticity of the contents included in the report. This confirmation was duly authorized on behalf of Apyx Medical Corporation on January 13, 2025.

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Bovie Medical’s 8K filing here.

About Bovie Medical

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME).